A Specialty-lite Strategy for Primary Care Therapies Now Integrates Real-Time Prescription Visibility, Proprietary BV Solutions, and DoorDash® Delivery. FLORHAM PARK,...
Rapidly growing pharmaceutical services platform unveils new integrated structure for global evidence solutions. NASHVILLE, Tenn., April 16, 2025 /PRNewswire/ -- Petauri,...
The Toolkit Fosters Safe and Inclusive Learning Environments for Students with EpilepsyBOWIE, Md., April 16, 2025 (GLOBE NEWSWIRE) -- The...
Vancouver, Canada, April 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
LA JOLLA, CA, April 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a...
MIAMI, FL, April 16, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes Vivani CEO...
NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or...
By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands...
FLORHAM PARK, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing...
Decoy’s development of novel peptide-conjugate therapeutics arising from its proprietary IMP3ACT™ platform to benefit from Dr. Langer’s extensive scientific knowledge...
Oral presentation will feature AI-081, a potentially best-in-class PD-1/VEGF bispecific antibody and ONC-841, a first-in-class anti-Siglec-10 antibody Initial clinical data...
Exemption from the $5.1 million repayment obligation strengthens LAVA’s balance sheet Underscores focus on cost curtailment and strategic option evaluation...
TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical...
Company-sponsored clinical trial will be initiated at FAU Erlangen-Nuremberg in Germany and Università Cattolica del Sacro Cuore, Rome in Q2...
Designed to assess the impact of CardiolRx™ on preventing episodes of recurrent pericarditis, the first patient has been randomized by...
Sponsorship will enhance, strengthen resources for the Northern Kentucky-based life sciences and entrepreneurship lab incubator COVINGTON, Ky., April 15, 2025...
WINSTON-SALEM, N.C., April 15, 2025 /PRNewswire/ -- Inmar Intelligence, a leader in healthcare solutions for hospitals, pharmacies and life sciences...
Agenda Focuses on Balancing Patient Access and Net Revenue Optimization Keynote Speaker Bill Roth Joins Industry Veterans, Practitioners, and Technologists...
The companies are now moving forward with the import permit application process.Following expected approval of the import permit, Red Light...